Showing 4761-4770 of 8208 results for "".
- Revance: FDA Accepts BLA for DaxibotulinumtoxinA, Sets November PDUFA Datehttps://practicaldermatology.com/news/revance-fda-accepts-bla-for-daxibotulinumtoxina-sets-november-pdufa-date/2460278/FDA has accepted the Biologics License Application (BLA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar (frown) lines, Revance reports. The FDA set an action date of November 25, 2020 under the Prescription Drug User Fee Act (PDUFA) VI program.
- Resident of Distinction Award Celebrates 10th Anniversary at 2020 Caribbean Dermatology Symposiumhttps://practicaldermatology.com/news/resident-of-distinction-award-celebrates-10th-anniversary-at-2020-caribbean-dermatology-symposium/2460276/As part of the dermMentors Resident of Distinction Award, Beiersdorf Inc. sponsored five top dermatology residents to attend the 2020 Caribbean Dermatology Symposium, held in Paradise Island, Bahamas, from Jan. 21-25, 2020.
- Ortho Dermatologics Opens 2020 Aspire Higher Scholarship Programhttps://practicaldermatology.com/news/ortho-dermatologics-opens-2020-aspire-higher-scholarship-program/2460273/Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics opened of the application process for its 2020 Aspire Higher scholarship program. The program, which began in 2012, will award nine students who have been treated for a dermatologic condition with a
- Derms Still Need Disaster Preparedness Traininghttps://practicaldermatology.com/news/derms-still-need-disaster-preparedness-training/2460271/The dermatology community is inadequately prepared for a biological disaster and would benefit from a formal preparedness training program, according to a study from the George Washington University (GW) that appears in the Jour
- SkinMedica Launches DiamondGlowhttps://practicaldermatology.com/news/skinmedica-launches-diamondglow/2460270/Allergan’s Skinmedica is rolling out DiamondGlow, a non-invasive dermabrasion technology that exfoliates, extracts, and treats the face, eye area, lips and body. Allergan acquired Envy Medical, Inc and its Silkpeel Dermalinfusion in 2
- Dermal Fillers Restore Youthful Facial Movement Toohttps://practicaldermatology.com/news/dermal-fillers-restore-youthful-facial-movement-too-1/2460269/Dermal fillers do more than just fill in wrinkles, they also restore a more youthful pattern of facial movement and expressiveness, according to a
- Mattel Releases New Barbie Dolls with Vitiligo, Alopeciahttps://practicaldermatology.com/news/mattel-releases-new-barbie-dolls-with-vitiligo-alopecia-1/2460268/In an effort to be more inclusive, Mattel, the maker of Barbie dolls, has released new dolls in its Fashionista line including a Barbie with alopecia and one with vitiligo. “For 2020, Barbie is continuing the journey to represent global diversity and inclusivity in the f
- Survey: Many Men Don’t Wash Their Faces Every Dayhttps://practicaldermatology.com/news/survey-many-men-dont-wash-their-faces-every-day/2460266/One-third of men admit to not washing their faces daily, according to a poll of 1,000 men aged 18 and older conducted by AcuPoll for Tiege Hanley. The Men’s Skin Care Survey by Tiege Hanley found that younger men are more likely to drop the
- SU2C Calls for Increased Diversity in Cancer Trialshttps://practicaldermatology.com/news/su2c-calls-for-increased-diversity-in-cancer-trials/2460265/Stand Up to Cancer (SU2C) announced a new diversity initiative that aims to make sure current advances in diagnosing and treating cancers don’t leave anyone out. The lack of diverse participation in cancer clinical trials may be due to socio-economic, cultural, trust and
- Final Data Support Efficacy of Revian Red System for Hair Growthhttps://practicaldermatology.com/news/final-data-support-efficacy-of-revian-red-system-for-hair-growth/2460260/Final data from a randomized, double-blind study of the Revian Red hair growth system demonstrated the ability of the system to successfully stop hair loss and subsequently grow new hair. Findings were presented at the 2020 Winter Clinical Dermatology Conference – Hawaii and are <